Literature DB >> 18192640

Periodic use of inhaled steroids in children with mild persistent asthma: what are pediatricians recommending?

Gregory S Sawicki1, Lauren Smith, Barbara Bokhour, Charlene Gay, Katherine H Hohman, Alison A Galbraith, Tracy A Lieu.   

Abstract

Although asthma treatment guidelines recommend daily inhaled corticosteroid (ICS) use for all persistent asthma, pediatricians may recommend alternative treatment plans for children with mild persistent disease. The authors administered a survey of pediatricians to describe prescribing patterns for mild persistent asthma. More than 99% of providers agreed that periodic ICS could be effective for some asthma patients. Overall, 129/251 providers (51%) reported prescribing daily ICS to most patients with mild persistent asthma, whereas 78 (31%) reported recommending periodic ICS for most such patients. Providers with patient populations > or = 25% black were significantly less likely to report prescribing daily ICS (odds ratio, 0.3; 95% confidence interval, 0.2-0.6) for mild persistent asthma. Further research is needed on the effectiveness of periodic ICS use for children with mild persistent asthma and on underlying reasons for differing provider practice patterns.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18192640     DOI: 10.1177/0009922807312184

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  9 in total

1.  Barriers to Prescribing Controller Anti Inflammatory Medication among Puerto Rican Asthmatic Children with Public Insurance: Results of National Survey of Pediatricians.

Authors:  Glorisa Canino; Doryliz Vila; Michael Cabana; Amarilis Quiñones; Mirla Otero; Edna Acosta; Karen Pabón-Cruz; Frances M Colón; Cynthia Rand
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-11-01       Impact factor: 1.349

2.  Patterns of inhaled corticosteroid use and asthma control in the Childhood Asthma Management Program Continuation Study.

Authors:  Gregory S Sawicki; Robert C Strunk; Brooke Schuemann; Robert Annett; Scott Weiss; Anne L Fuhlbrigge
Journal:  Ann Allergy Asthma Immunol       Date:  2010-01       Impact factor: 6.347

3.  Preventive asthma care delivery in the primary care office: missed opportunities for children with persistent asthma symptoms.

Authors:  Alison B Yee; Maria Fagnano; Jill S Halterman
Journal:  Acad Pediatr       Date:  2013-01-05       Impact factor: 3.107

4.  Addressing asthma health disparities: a multilevel challenge.

Authors:  Glorisa Canino; Elizabeth L McQuaid; Cynthia S Rand
Journal:  J Allergy Clin Immunol       Date:  2009-05-17       Impact factor: 10.793

5.  Asthma care quality for children with minority-serving providers.

Authors:  Alison A Galbraith; Lauren A Smith; Barbara Bokhour; Irina L Miroshnik; Gregory S Sawicki; James H Glauber; Katherine H Hohman; Charlene Gay; Tracy A Lieu
Journal:  Arch Pediatr Adolesc Med       Date:  2010-01

6.  Outcomes after periodic use of inhaled corticosteroids in children.

Authors:  Ann Chen Wu; Lingling Li; Irina Miroshnik; James Glauber; Charlene Gay; Tracy A Lieu
Journal:  J Asthma       Date:  2009-06       Impact factor: 2.515

7.  Mismatching Among Guidelines, Providers, and Parents on Controller Medication Use in Children with Asthma.

Authors:  Ann Chen Wu; Lingling Li; Vicki Fung; Elyse O Kharbanda; Emma K Larkin; Melissa G Butler; Alison Galbraith; Irina Miroshnik; Robert L Davis; Kelly Horan; Tracy A Lieu
Journal:  J Allergy Clin Immunol Pract       Date:  2016-05-17

8.  Analysis of the predicting factors of recurrent wheezing in infants.

Authors:  Jia Zhai; Yingxue Zou; Jie Liu; Xingnan Jin; Cuian Ma; Jiao Li; Run Guo; Bing Huang
Journal:  Ital J Pediatr       Date:  2019-01-29       Impact factor: 2.638

9.  General practitioners' prescribing behaviour as a determinant of poor persistence with inhaled corticosteroids in children with respiratory symptoms: mixed methods study.

Authors:  Ted Klok; Ad A Kaptein; Eric Duiverman; Frank S Oldenhof; Paul L P Brand
Journal:  BMJ Open       Date:  2013-04-03       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.